Clobenpropit, an H 3 receptor antagonist, has been reported to modulate both the release of neurotransmitters and also the activity of histidine decarboxylase (HDC). Therefore, a decarboxylase-positive modulator, namely pyridoxine, was taken for interaction studies with clobenpropit in the electroshock (ES) model of seizures in mice and subsequent changes in brain histamine levels were estimated. A significant inhibition of ES-induced seizures was seen after the simultaneous use of clobenpropit and pyridoxine. No significant effects were evident on the brain histamine levels following this combination. The combination of clobenpropit with pyridoxine appears to exhibit beneficial pharmacodynamic interaction for the prevention of ES-induced seizures, which might not be mediated by the histaminergic mechanisms.
Hirai T., Okuma C., Harada C., Mio M., Ohtsu H., Watanabe T., et al. Development of amygdaloid kindling in histidine decarboxylase-deficient and histamine H1 receptor-deficient mice. Epilepsia2004; 45: 309-313.
2.
Kamei C.Involvement of central histamine in amygdaloid kindled seizures in rats. Behav Brain Res2001; 124: 243-250.
3.
Nishida N., Huang ZL, Mikuni N., Miura Y., Urade Y., Hashimoto N.Deep brain stimulation of the posterior hypothalamus activates the histaminergic system to exert antiepileptic effect in rat pentylenetetrazole model. Exp Neurol2007; 205: 132-144.
4.
Vohora D., Pal SN, Pillai KKHistamine and selective H3-receptor ligands: a possible role in the mechanism and management of epilepsy. Pharmacol Biochem Behav2001; 68: 735-741.
5.
Vohora D., Pal SN, Pillai KKHistamine as an anticonvulsant inhibitory neurotransmitter. Curr Neuropharmacol2004; 2: 419-425.
6.
Yawata I., Tanaka K., Nakagawa Y., Watanabe Y., Murashima YL, Nakano K.Role of histaminergic neurons in development of epileptic seizures in EL mice . Mol Brain Res2004; 132: 13-17.
7.
Arrang JM, Garbarg M., Schwartz JCAuto-inhibition of brain histamine release mediated by a novel class H3 of histamine receptor. Nature1983; 302: 832-837.
8.
Jansen FP, Mochizuki T., Yamamoto Y., Timmerman H., Yamatodani A. In vivo modulation of rat hypothalamic histamine release by the histamine H3 receptor ligands, immepip and clobenpropit. Effects of intrahypothalamic and peripheral application. Eur J Pharmacol1998 ; 362: 149-155.
9.
Yokoyama H., Onodera K., Maeyama K., Sakurai E., Iinuma K., Leurs R., et al. Clobenpropit (VUF-9153), a new histamine H3 receptor antagonist, inhibits electrically induced convulsions in mice. Eur J Pharmacol1994; 260: 23-28.
10.
Lee NS, Muhs G., Wagner GC, Reynolds RD, Fisher H.Dietary pyridoxine interaction with tryptophan or histidine on brain serotonin and histamine metabolism. Pharmacol Biochem Behav1988; 29: 559-564.
11.
Schlesinger K., Lieff B.Levels of pyridoxine and susceptibility to electroconvulsive and audiogenic seizures. Psychopharmacol (Berl) 1975; 42: 27-32.
Sharma SK, Bolster B., Dakshinamurti K.Picrotoxin and pentylenetetrazole induced seizure activity in pyridoxine-deficient rats. J Neurol Sci1994; 121: 1-9.
14.
Dakshinamurti K., Sharma SK, Geiger JDNeuroprotective actions of pyridoxine. Biochem Biophys Acta2003 ; 1647: 225-229.
15.
Shore PA, Burkhalter A., Cohn VH Jr.A method for the fluorometric assay of histamine in tissues. J Pharmacol Exp Ther1959; 127: 182-186.
16.
Jin CL, Zhuge ZB, Wu DC, Zhu YY, Wang S., Luo JH, et al. Lesion of the tuberomammillary nucleus E2-region attenuates postictal seizure protection in rats. Epilepsy Res2007; 73: 250-258.
17.
Fischer W., Van der Goot H.Effect of clobenpropit, a centrally acting histamine H3-receptor antagonist, on electroshock- and pentylenetetrazole-induced seizures in mice. J Neural Transm1998; 105: 587-599.
18.
Arrang JM, Garbarg M., Schwartz JCAutoinhibition of histamine synthesis mediated by presynaptic H3-receptors . Neurosci1987; 23: 149-157.
19.
Dai H., Fu Q., Shen Y., Hu W., Zhang Z., Timmerman H., et al. The histamine H3 receptor antagonist clobenpropit enhances GABA release to protect against NMDAinduced excitotoxicity through the cAMP/protein kinase A pathway in cultured cortical neurons. Eur J Pharmacol2007; 563: 117-123.
20.
Ericson H., Kohler C., Blomqvist A.GABA-like immunoreactivity in the tuberomammillary nucleus: an electron microscopic study in the rat. J Comp Neurol1991; 305: 462-469.
21.
Sakai N., Sakurai E., Onodera K., Sakurai E., Asada H., Miura Y., et al. Long-term depletion of brain histamine induced by alpha-fluoromethylhistidine increases feeding-associated locomotor activity in mice with a modulation of brain amino acid levels. Behav Brain Res1995; 72: 83-88.
22.
Ishizawa K. , Chen Z., Okuma C., Sugimoto Y., Fujii Y., Kamei C.Participation of GABAergic and histaminergic systems in inhibiting amygdaloid kindled seizures . Jpn J Pharmacol2000; 82: 48-53.
23.
Bender DA, Mayes PAVitamins and minerals. In: Murray RK, Granner DK, Mayes PA , Rodwell VW (eds) Harper’s Illustrated Biochemistry. 26th ed. India: McGraw Hill, 2003, p.481-497.
24.
Tapia R., Pasantes H.Relationships between pyridoxal phosphate availability, activity of vitamin B6-dependent enzymes and convulsions. Brain Res1971; 29: 111-122.
25.
Abe M., Matsuda M.Effect of antivitamin B6 on regional GABA metabolism in mouse brain and its relation to convulsions. J Nutr Sci Vitaminol1979; 25: 459-468.
